StockData
Rapport Therapeutics, Inc. logo

Rapport Therapeutics, Inc. (RAPP) stock

RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$23.76−1.06 (-4.27%)

Close on Nov 17, 2026Market cap $1.14BP/E –Yield –

Rapport Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Rapport Therapeutics's market cap was $1.30B on Nov 11, 2026, against $1.42B a year earlier. Over the last 3 years it ranged from $94.76M to $2.33B, with a median of $1.06B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.30B-10.4%
2025Dec 31, 2025$1.45B+122.8%
2024Dec 31, 2024$648.87M–

More Rapport Therapeutics figures

See a number that looks wrong?